Lyell Immunopharma, Inc.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2021 | $197.6M | $1.13B | $293.8M |
| FY2022 | $104.3M | $937.6M | $123.6M |
| FY2023 | $95.1M | $750.0M | $145.6M |
| FY2024 | $108.0M | $490.9M | $105.6M |
| FY2025 | $91.9M | $340.1M | $60.2M |